Akero Therapeutics
company0.0Global Dominance: 0.00%
Akero Therapeutics is an American biotechnology company that specializes in therapeutics for metabolic diseases, particularly known for its development of treatments targeting liver diseases such as MASH. The company has recently garnered attention following its acquisition by Novo Nordisk, which aims to expand its portfolio in metabolic medicine.
Power0
Reach0
Collect
Not in the pool (under ¢1).
Recent news mentions
Novo Nordisk announced an agreement to acquire Akero Therapeutics, which works on treatments for metabolic diseases.
Pfizer trækker Novo i retten i kamp om selskab med anderledes vægttabsmedicinPolitiken·
Denmark· 2025-11-01
Denmark· 2025-11-01
Novo announced that it had entered into an agreement to acquire the American biotech company Akero Therapeutics.
Pfizer trækker Novo i retten i kamp om firma med anderledes vægttabsmedicinPolitiken·Denmark· 2025-10-31
Denmark· 2025-10-31